BioCentury | Nov 5, 2012
Strategy

Racing to rebuild AZ

...tuberculosis (MDR-TB) and identify combination treatments Discovery >$1M in funding from the Wellcome Trust Jul-12 Conformetrix Ltd....
BioCentury | Apr 30, 2012
Tools & Techniques

Confirming conformations

...improve the efficiency and quality of lead identification and optimization, as well as candidate selection. Conformetrix...
...it does not always work with targets like GPCRs and ion channels, according to Williams. Conformetrix's...
...then they completely rewrote all the software for analyzing NMR data." The result is that Conformetrix...
BioCentury | Apr 23, 2012
Company News

Conformetrix, AstraZeneca deal

...AstraZeneca and Conformetrix partnered to use Conformetrix's nuclear magnetic resonance (NMR)-based technology to enhance lead discovery...
...to enhance lead discovery and hit identification in AstraZeneca's preclinical pipeline. Under the two-year deal, Conformetrix...
...the bioactive conformations of naturally occurring ligands as templates for library enhancement and hit identification. Conformetrix...
BioCentury | Apr 17, 2012
Company News

AstraZeneca, Conformetrix in discovery deal

...AstraZeneca plc (LSE:AZN; NYSE:AZN) and Conformetrix Ltd. (Manchester, U.K.) partnered to use Conformetrix's NMR-based technology to enhance...
...to enhance lead discovery and hit identification in AstraZeneca's preclinical pipeline. Under the two-year deal, Conformetrix...
...the bioactive conformations of naturally occurring ligands as templates for library enhancement and hit identification. Conformetrix...
BioCentury | Mar 12, 2012
Company News

Conformetrix management update

Conformetrix Ltd. , Manchester, U.K. Business: Computational chemistry/biology Hired: Sam Williams, formerly a non-executive director, as CEO; he replaces Andrew Almond who becomes chief technology officer WIR Staff...
Items per page:
1 - 5 of 5
BioCentury | Nov 5, 2012
Strategy

Racing to rebuild AZ

...tuberculosis (MDR-TB) and identify combination treatments Discovery >$1M in funding from the Wellcome Trust Jul-12 Conformetrix Ltd....
BioCentury | Apr 30, 2012
Tools & Techniques

Confirming conformations

...improve the efficiency and quality of lead identification and optimization, as well as candidate selection. Conformetrix...
...it does not always work with targets like GPCRs and ion channels, according to Williams. Conformetrix's...
...then they completely rewrote all the software for analyzing NMR data." The result is that Conformetrix...
BioCentury | Apr 23, 2012
Company News

Conformetrix, AstraZeneca deal

...AstraZeneca and Conformetrix partnered to use Conformetrix's nuclear magnetic resonance (NMR)-based technology to enhance lead discovery...
...to enhance lead discovery and hit identification in AstraZeneca's preclinical pipeline. Under the two-year deal, Conformetrix...
...the bioactive conformations of naturally occurring ligands as templates for library enhancement and hit identification. Conformetrix...
BioCentury | Apr 17, 2012
Company News

AstraZeneca, Conformetrix in discovery deal

...AstraZeneca plc (LSE:AZN; NYSE:AZN) and Conformetrix Ltd. (Manchester, U.K.) partnered to use Conformetrix's NMR-based technology to enhance...
...to enhance lead discovery and hit identification in AstraZeneca's preclinical pipeline. Under the two-year deal, Conformetrix...
...the bioactive conformations of naturally occurring ligands as templates for library enhancement and hit identification. Conformetrix...
BioCentury | Mar 12, 2012
Company News

Conformetrix management update

Conformetrix Ltd. , Manchester, U.K. Business: Computational chemistry/biology Hired: Sam Williams, formerly a non-executive director, as CEO; he replaces Andrew Almond who becomes chief technology officer WIR Staff...
Items per page:
1 - 5 of 5